BrightSpring Health Services, Inc. (BTSG)
| Market Cap | 10.01B +170.6% |
| Revenue (ttm) | 12.91B +28.2% |
| Net Income | 190.67M |
| EPS | 0.86 |
| Shares Out | 204.90M |
| PE Ratio | 56.55 |
| Forward PE | 31.41 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,399,015 |
| Open | 48.23 |
| Previous Close | 48.16 |
| Day's Range | 47.63 - 48.90 |
| 52-Week Range | 16.34 - 48.87 |
| Beta | 2.05 |
| Analysts | Strong Buy |
| Price Target | 47.78 (-2.23%) |
| Earnings Date | May 1, 2026 |
About BTSG
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for BTSG stock is "Strong Buy." The 12-month stock price target is $47.78, which is a decrease of -2.23% from the latest price.
News
BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026
LOUISVILLE, Ky., April 07, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2026 ...
BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita
LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and hea...
BrightSpring Health Services Transcript: Investor Day 2026
Revised summary: The company’s strategy focuses on integrated home and community health, using scale, technology, and operational excellence for double-digit growth in pharmacy and provider segments. Guidance projects 15–20% organic EBITDA CAGR through 2028, backed by strong cash flow, disciplined M&A, AI investment, and regulatory engagement.
BrightSpring Health Services Transcript: Leerink Global Healthcare Conference 2026
Lean culture, centralized procurement, and AI initiatives are driving operational efficiency and margin improvement. Specialty pharmacy and infusion segments are growing through new therapies, LDD wins, and selective M&A, while provider businesses like Hospice and Home Health show strong performance and integration. Financial flexibility is increasing as leverage declines.
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
LOUISVILLE, Ky., March 02, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services ...
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
LOUISVILLE, Ky., March 02, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services ...
BrightSpring Health Services Transcript: TD Cowen 46th Annual Health Care Conference
Broad-based growth is expected across pharmacy and provider services, with strong EBITDA guidance and margin expansion driven by operational efficiencies, generics, and LDD launches. IRA headwinds are being mitigated, and integration of new assets plus a robust M&A pipeline support future growth.
BrightSpring Health Services Earnings Call Transcript: Q4 2025
Delivered 28% revenue and 34% adjusted EBITDA growth in 2025, exceeding guidance, with strong performance across segments and successful strategic acquisitions. 2026 guidance projects 12–16% revenue and 23–28% adjusted EBITDA growth, supported by operational efficiencies and integration of new assets.
BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services f...
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
LOUISVILLE, Ky., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it will host an Investor Day on Tuesday, Mar...
BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
LOUISVILLE, Ky., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its fourth quarter and f...
BrightSpring Health Services Transcript: Bank of America Home Care Conference
Specialty pharmacy and provider businesses delivered strong growth, driven by new drug launches, generic conversions, and operational efficiencies. Investments in technology, expansion, and high-quality services support continued outperformance, while regulatory and market headwinds are being managed through scale and innovation.
BrightSpring Health Services Transcript: UBS Global Healthcare Conference 2025
Strong growth and operational efficiency marked the year, with pharmacy and provider segments showing broad-based momentum. Strategic investments in technology, M&A, and automation are set to continue, while regulatory and industry changes are being proactively managed.
BrightSpring Health Services Earnings Call Transcript: Q3 2025
Q3 2025 saw 28% revenue growth and 37% adjusted EBITDA growth, driven by strong performance in specialty and infusion pharmacy and provider services. Guidance for 2025 was raised, with continued margin expansion, robust cash flow, and leverage improvement expected.
BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
LOUISVILLE, Ky., Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services f...
BrightSpring Health Services, Inc. to Announce Third Quarter 2025 Financial Results on October 31, 2025
LOUISVILLE, Ky., Oct. 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2025 f...
BrightSpring Health Services Transcript: Jefferies 2025 Healthcare Services Conference
A leading home and community healthcare provider highlighted strong, broad-based growth across pharmacy, provider, and primary care platforms, driven by innovation, scale, and integrated services. Strategic M&A, disciplined capital deployment, and a focus on value-based care underpin future growth, while regulatory risks are actively managed.
BrightSpring Health Services Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference
Following a major divestiture, the business is focused on pharmacy and provider services for home and community markets, leveraging organic growth, M&A, and de novo expansion. Specialty pharmacy and infusion are key growth drivers, supported by operational efficiency, robust M&A, and technology investments. Double-digit growth is expected across core segments, with a strong outlook through 2026.
BrightSpring Health Services Earnings Call Transcript: Q2 2025
Q2 2025 saw 29% revenue and adjusted EBITDA growth, driven by strong pharmacy and provider performance. Full-year guidance was raised, with continued momentum expected from specialty pharmacy, infusion, and efficiency initiatives. Leverage reduction and M&A remain priorities.
BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
LOUISVILLE, Ky., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services f...
BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 ...
BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud to announce that its specialty pharmacy, Onco...
BrightSpring Health Services Transcript: Goldman Sachs 46th Annual Global Healthcare Conference 2025
Leadership emphasized a proven growth strategy, strong M&A execution, and a focus on quality and technology. Outperformance in pharmacy and provider segments, driven by specialty drugs and integrated care, supports double-digit growth and robust guidance. Margin expansion and regulatory navigation remain priorities.
BrightSpring Announces Pricing of Secondary Offering of Common Stock
LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services f...
BrightSpring Announces Secondary Offering of Common Stock
LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services f...